Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 374.50
Bid: 377.00
Ask: 379.50
Change: -6.50 (-1.71%)
Spread: 2.50 (0.663%)
Open: 382.00
High: 382.50
Low: 374.50
Prev. Close: 381.00
CHG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

12 Sep 2022 09:00

RNS Number : 9881Y
Chemring Group PLC
12 September 2022
 

FOR IMMEDIATE RELEASE 12 SEPTEMBER 2022

 

CHEMRING GROUP PLC

NOTICE OF RESULTS

 

Chemring Group PLC ("Chemring" or "the Group") will announce its results for the year ended 31 October 2022 on Tuesday 13 December 2022 at 7am.

 

An analyst meeting will take place at 09.00 (UK time) at the offices of Investec Bank plc, 30 Gresham Street, London EC2V 7QP. To confirm attendance please contact MHP Communications: chemringplc@mhpc.com / tel: +44 (0) 20 3128 8826.

 

Ahead of the results, a trading update will be published on Thursday 6 October 2022.

 

For further information:

Rupert Pittman Group Director of Corporate Affairs, 01794 463401

Chemring Group PLC

 

Andrew Jaques MHP Communications 0203 128 8170

Cautionary statement

This announcement contains forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements. There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are: increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects. Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

Notes to editors

 

· Chemring is a FTSE-250 listed global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

· Employing approximately 2,300 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is organised under two strategic product sectors: Sensors & Information and Countermeasures & Energetics

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development, Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORXKLFBLKLEBBK
Date   Source Headline
31st May 20173:13 pmRNSHolding(s) in Company
2nd May 20172:37 pmRNSTotal Voting Rights
3rd Apr 20179:30 amRNSTotal Voting Rights
31st Mar 201711:47 amRNSHolding(s) in Company
24th Mar 20171:54 pmRNSDirector/PDMR Shareholding
24th Mar 20171:53 pmRNSDirector/PDMR Shareholding
24th Mar 20171:51 pmRNSDirector/PDMR Shareholding
20th Mar 20177:00 amRNSResults of AGM
17th Mar 20177:00 amRNSAGM Statement
17th Mar 20177:00 amRNSWithdrawal of AGM resolutions
1st Mar 20173:03 pmRNSTotal Voting Rights
1st Mar 20172:11 pmRNSHolding(s) in Company
28th Feb 20179:27 amRNSHolding(s) in Company
22nd Feb 201711:38 amRNSAdditional Listing
21st Feb 20171:50 pmRNSBlock listing Interim Review
15th Feb 20179:48 amRNSNotice of AGM
13th Feb 20177:00 amRNSCONTRACT AWARD
1st Feb 201710:56 amRNSTotal Voting Rights
30th Jan 201711:13 amRNSDirector/PDMR Shareholding
24th Jan 20179:27 amRNSDirector/PDMR Shareholding
20th Jan 201711:08 amRNSDirector/PDMR Shareholding
20th Jan 201711:05 amRNSDirector/PDMR Shareholding
19th Jan 20172:13 pmRNSDirector/PDMR Shareholding
19th Jan 20177:00 amRNSFinal Results
3rd Jan 201710:00 amRNSTotal Voting Rights
13th Dec 20167:00 amRNSDirectorate Change
1st Dec 20169:34 amRNSTotal Voting Rights
21st Nov 20167:00 amRNSPOST-CLOSE STATEMENT
1st Nov 20169:40 amRNSTotal Voting Rights
3rd Oct 201610:10 amRNSTotal Voting Rights
29th Sep 201610:53 amRNSContract Win
1st Sep 20169:05 amRNSTotal Voting Rights
31st Aug 20167:00 amRNSQ3 UPDATE
25th Aug 20163:32 pmRNSHolding(s) in Company
17th Aug 201611:31 amRNSHolding(s) in Company
12th Aug 20169:34 amRNSDirector/PDMR Shareholding
3rd Aug 20169:43 amRNSTotal Voting Rights
28th Jul 201612:29 pmRNSDirector/PDMR Shareholding
22nd Jul 201610:07 amRNSHolding(s) in Company
21st Jul 20167:00 amRNSContract Win
18th Jul 20163:41 pmRNSHolding(s) in Company
4th Jul 20162:22 pmRNSHolding(s) in Company
1st Jul 20169:50 amRNSTotal Voting Rights
29th Jun 20167:00 amRNSDirectorate Change
28th Jun 20169:20 amRNSHolding(s) in Company
23rd Jun 201611:21 amRNSHolding(s) in Company
22nd Jun 20169:15 amRNSDirector/PDMR Shareholding
21st Jun 20161:12 pmRNSDirector/PDMR Shareholding
21st Jun 20167:00 amRNSINTERIM RESULTS
20th Jun 20162:39 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.